Dr. Mark McClellan, a physician and economist who has served both the commissioner of the U.S. Food and Drug Administration (FDA) and administrator of the Centers for Medicare & Medicaid Services, was hired by Blackstone as a senior advisor for the firm’s private equity business lines.
He will bring his expertise across the life sciences and healthcare and public sectors to advise on the work of Blackstone Growth and Blackstone Life Sciences.
Blackstone’s private equity business saw its assets jump 40% in 2019 to a record $183 billion with inflows of $57 . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Annual
$300
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
